AMID vs IQSM
Argent Mid Cap ETF vs NYLIM Candriam US Mid Cap Equity ETF
Which is better, AMID or IQSM?
Each has led over a different period.
IQSM has a lower expense ratio. AMID led over the full window, IQSM over 1Y and 3Y. The two have moved almost in lockstep, correlation 0.92. IQSM is less concentrated, with 8.3% of the fund in its ten largest positions against 31.5%.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | AMID | IQSM |
|---|---|---|
| Expense Ratio | 0.52% | 0.15%Best |
| AUM | $119M | $360M |
| Dividend Yield | 0.33% | 1.07% |
| Holdings | 48 | 248 |
| YTD Return | +7.28% | +10.14%Best |
| 1Y Return | +6.87% | +14.22%Best |
| 3Y Return (annualized) | +12.21% | +14.53%Best |
| Volatility (annualized) | 16.8% | 16.5%Best |
| Max Drawdown | -23.1%Best | -23.7% |
| $10,000 over 4 years | $16,069Best | $15,590 |
| Top 10 Weight | 31.5% | 8.3%Best |
| Fund Family | Alpha Architect | New York Life Investments |
| Category | Equity | Equity |
| Style | Mid Cap Blend | Mid Cap Blend |
| Inception | Aug 17, 2022 | Oct 25, 2022 |
Not shown on this pair: 5Y Return (annualized).
Volatility and max drawdown, and the $10,000 over 4 years row, are measured over the window both funds cover: Oct 25, 2022 to Oct 14, 2026 (4 years).
AMID vs IQSM growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 4 years both funds cover.
AMID vs IQSM Performance
Argent Mid Cap ETF (AMID) is an ETF from Alpha Architect and NYLIM Candriam US Mid Cap Equity ETF (IQSM) is an ETF from New York Life Investments. Over the past year AMID returned +6.87% while IQSM returned +14.22%. Year to date, AMID is up 7.28% versus a gain of 10.14% for IQSM.
Over three years, AMID compounded at +12.21% per year against +14.53% for IQSM. Across the full 4-year window we track, AMID has the edge at +12.59% annualized vs +11.74%.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
AMID has been the more volatile fund, with annualized monthly volatility of 16.8% compared with 16.5% for IQSM. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -23.1% for AMID and -23.7% for IQSM. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.92. They move almost in lockstep, so holding both mostly duplicates the same exposure.
Fees and Cost Over Time
AMID charges 0.52% per year while IQSM charges 0.15%. On a $10,000 position that is $52 vs $15 annually, a gap of $37 per year that compounds over a long holding period. On income, AMID currently yields 0.33% against 1.07% for IQSM.
Holdings Overlap
27.8% of AMID's money is in holdings IQSM also owns. 7.5% of IQSM's money is in holdings AMID also owns.
AMID and IQSM share little of their money.
14 positions in common, counted across the 47 positions we hold weights for in AMID and 246 in IQSM, against full books of 48 and 248.
What only one of them owns
Our book lists 224 positions for IQSM that do not appear in our book for AMID (89.5% of the fund), and 29 for AMID that do not appear in IQSM (64.0%).
Some of those will be the same company recorded under a different code in one of the two books, so the real difference in what you would own is no larger than this and may be smaller. We do not name the individual positions here for that reason.
Top Shared Holdings
| Stock | Weight in AMID | Weight in IQSM | Difference |
|---|---|---|---|
| MEDPMedpace Holdings Inc | 3.44% | 0.57% | 2.87% |
| USFDUS Foods Holding Corp | 2.49% | 0.84% | 1.65% |
| SNXSynnex Corp | 2.53% | 0.79% | 1.74% |
| VTRSViatris | 2.04% | 0.82% | 1.22% |
| ONTOOnto Innovation Inc | 2.12% | 0.69% | 1.43% |
| CLHClean Harbors Inc | 2.02% | 0.65% | 1.37% |
| HLIHoulihan Lokey Inc | 2.22% | 0.28% | 1.94% |
| NBIXNeurocrine Biosciences Inc | 1.66% | 0.58% | 1.08% |
| CHRWCh Robinson Worldwide Inc. | 1.53% | 0.68% | 0.85% |
| JAZZJazz Pharmaceuticals Plc. | 1.57% | 0.57% | 1.00% |
27.8% of AMID is already inside IQSM.
You probably hold more than these two. Add the rest and see how much of the whole book is the same companies twice.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, AMID or IQSM?
AMID has an expense ratio of 0.52% while IQSM charges 0.15%. IQSM is the cheaper option, by $37 a year on a $10,000 investment.
Which performed better, AMID or IQSM?
Over the past year AMID returned +6.87% vs +14.22% for IQSM, so IQSM leads on 1-year performance. Over the longest common window we track (4 years), AMID annualized +12.59% vs +11.74% for IQSM. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, AMID or IQSM?
AMID has been the more volatile fund at 16.8% annualized versus 16.5% for IQSM. Worst drawdown: AMID -23.1% vs IQSM -23.7%.
Should I hold both AMID and IQSM?
AMID and IQSM have a monthly-return correlation of 0.92, so they move almost identically. What is left to separate them is the fee and the index each one tracks. This is information, not a recommendation.
What is the holdings overlap between AMID and IQSM?
27.8% of AMID's money is in holdings IQSM also owns. 7.5% of IQSM's is in holdings AMID also owns. They hold 14 positions in common, counted across the 47 positions we hold weights for in AMID and 246 in IQSM.
Which pays a higher dividend, AMID or IQSM?
AMID yields 0.33% while IQSM yields 1.07%, so IQSM currently pays the higher dividend yield.
Is IQSM better than AMID?
IQSM has a lower expense ratio. AMID led over the full window, IQSM over 1Y and 3Y. The two have moved almost in lockstep, correlation 0.92. IQSM is less concentrated, with 8.3% of the fund in its ten largest positions against 31.5%. Which one suits a particular account depends on what it is for. This is information, not a recommendation.